Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
08/08/1991 | WO1991011174A1 Method for preventing immune suppression in trauma patients |
08/07/1991 | WO1991012022A1 Immune complexes |
08/07/1991 | EP0440333A2 Dopamine agonists for treating type II diabetes |
08/07/1991 | EP0440102A1 Method for treating renal disease |
08/07/1991 | EP0439513A1 Composition for inhibiting transmission of aids. |
08/07/1991 | EP0354921A4 Use of melatonin for the manufacture of a contraceptive composition |
08/07/1991 | EP0180581B1 Drug preparations of reduced toxicity |
08/07/1991 | CA2073964A1 Immune complexes |
08/06/1991 | US5037883 Hydroxypropylmethacrylamide polymer with peptide side chains to which are attached drugs for delivery to target cells |
08/01/1991 | DE4002840A1 Treating stress-induced regulation disorders - by exposing patient to additional stress and then administering drug e.g. substance P or butiroxan |
08/01/1991 | CA2035163A1 Method for treating renal disease |
07/31/1991 | EP0439430A2 Transdermal administration of zwitterionic drugs |
07/31/1991 | EP0438756A1 Combination of cytostatic and cytotoxic active agents for use in therapeutic procedures |
07/30/1991 | US5036097 Antiinflammatory agents/non-steriodal |
07/30/1991 | US5036046 Method for enhancing healing of corneal endothelial wounds |
07/24/1991 | EP0437488A1 Animal model for human disease |
07/23/1991 | US5034400 Method for preventing neurotoxic side effects of NMDA antagonists |
07/23/1991 | CA2034516A1 Transdermal administration of zwitterionic drugs |
07/17/1991 | EP0437368A1 Fluid ophthalmic composition based on lipid microparticles containing at least one active principle |
07/17/1991 | EP0437294A1 Oral pharmaceutical compositions in unit dosage form |
07/17/1991 | EP0437025A2 Compositions containing aldose reductase inhibitors for the treatment of ulcers |
07/17/1991 | EP0436717A1 Method of treatment with medical agents |
07/16/1991 | US5032591 Hypotensive |
07/16/1991 | US5032578 Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
07/16/1991 | US5032575 Epidermal growth factor or homolog thereof |
07/11/1991 | WO1991009627A1 Medicament for treatment of heart failure |
07/10/1991 | EP0436492A2 R-Enantiomer of N-propargyl-1-aminoindan, its preparation and pharmaceutical compositions containing it |
07/10/1991 | EP0436469A1 Composition and method for the treatment of osteoporosis in mammals |
07/10/1991 | CA2033870A1 Oral pharmaceutical compositions in unit dosage form |
07/03/1991 | EP0435362A1 Composition comprising non-steroidal anti-inflammatory agent and effectively non-antibacterial tetracycline |
07/03/1991 | EP0425507A4 Compositions and methods for treating skin conditions and promoting wound healing |
07/02/1991 | US5028627 Controlling blood pressure during chemotherapy |
07/02/1991 | CA1285480C Plasma exchange composition |
07/02/1991 | CA1285479C Immunostimulant agents |
06/30/1991 | WO1991010142A1 Determining the diuretic potency of candidate drugs |
06/30/1991 | CA2072564A1 Determining the diuretic potency of candidate drugs |
06/27/1991 | WO1991008770A1 Method for antibody targeting of diagnostic or therapeutic agents |
06/27/1991 | WO1991008740A1 The use of gaba-b selective agonists as anti-tussive agents |
06/26/1991 | EP0434257A2 Chimeric antibody for detection and therapy of infectious and inflammatory lesions |
06/26/1991 | EP0434173A2 Use of NMDA receptor antagonists for treatment of chronic neurodegenerative diseases |
06/26/1991 | EP0433766A1 Compositions of antiallergics and antihistamines and methods for their use |
06/26/1991 | EP0433765A1 The use of immunomodulants as synergistic agents of chemotherapeutics in tumor therapy |
06/26/1991 | EP0433683A2 Use of benzothiazepines as potentiators of anti-cancer drugs |
06/26/1991 | EP0433442A1 Hybrid molecules |
06/26/1991 | EP0433402A1 Therapeutic compounds, compositions and uses thereof |
06/26/1991 | CN1052478A Lmproved process for preparing vinyl ethers |
06/25/1991 | CA1285227C Long lasting dihydropyridine calcium channel blockers |
06/19/1991 | EP0433043A1 Medicaments |
06/19/1991 | CA2031593A1 Compositions of antiallergics and antihistamines and methods for their use |
06/18/1991 | US5025019 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
06/18/1991 | US5025017 Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates |
06/15/1991 | WO1991009002A1 Process for the preparation of vinyl ethers |
06/14/1991 | WO1991008739A1 Growth arrest of proliferating cells by transglutaminase inhibitors |
06/14/1991 | CA2071550A1 Growth arrest of proliferating cells by transglutaminase inhibitors |
06/14/1991 | CA2032049A1 Medicaments |
06/13/1991 | WO1991007998A1 IMPROVED SYSTEM FOR THE TRANSDERMAL APPLICATION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS AT CONTROLLED pH |
06/13/1991 | WO1991007987A1 Chimeric antibody for detection and therapy of infectious and inflammatory lesions |
06/13/1991 | WO1991002062A3 C-erbb-2 external domain: gp75 |
06/12/1991 | EP0431536A1 A method of preparation of an extract from Gingko biloba leaves. |
06/12/1991 | EP0431519A1 System for transdermal albuterol administration |
06/11/1991 | US5023073 Method of combating flupropadine poisoning using phenothiazines |
06/06/1991 | DE3939703A1 Verbesserte transdermale applikation von pharmakologisch aktiven verbindungen Improved transdermal application of pharmacologically active compounds |
06/05/1991 | WO1991007986A1 Method of treating septic shock |
06/05/1991 | EP0430539A2 Ocular implants |
06/05/1991 | EP0430474A1 Sustained release compositions for treating periodontal disease |
06/05/1991 | CA2070424A1 Method of treating septic shock |
06/05/1991 | CA2031433A1 Use of nmda receptor antagonists |
06/05/1991 | CA2031386A1 Extract from ginkgo biloba leaves, its method of preparation and pharmaceuticals containing the extract |
06/05/1991 | CA2031376A1 Single layer transdermal drug administration system |
06/04/1991 | US5021448 Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist |
06/04/1991 | US5021437 2-acetylpyridine 5-[(2-chloroanilino)thiocarbonyl]thiocarbonohydrazone compound and salts thereof |
06/04/1991 | US5021410 Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure |
06/04/1991 | US5021404 Administering proline hydroxylase inhibitors, collagen crosslinking inhibitors or trans-retinoic acid |
06/04/1991 | US5021234 Agent and product for the diagnosis and treatment of tumors and for the treatment of weaknesses of the cellular and humoral immune defense |
05/29/1991 | EP0429225A1 Sustained release compositions for treating periodontal disease |
05/29/1991 | EP0429224A1 Use of monoolein in the treatment of the periodontal pocket |
05/29/1991 | EP0428772A1 Treatment of colic and teething |
05/29/1991 | DE4037708A1 Appetite suppressant contg. indirect sympathomimetic cpd. and tyrosine - has tyrosine and phenyl:propanolamine, amphetamine and/or ephedrine, which act with tyrosine |
05/29/1991 | CA2027815A1 Method and composition for decreasing appetite |
05/28/1991 | US5019594 Administring A Sympathomimetric Drug And Tyrosine |
05/28/1991 | US5019381 Method for lowering cholesterol levels using GM-CSF |
05/23/1991 | CA2030159A1 Anti-cancer drug potentiators |
05/22/1991 | WO1991007175A1 Use of optically pure s(-) atenolol for the treatment of cardiovascular disorders |
05/22/1991 | EP0428296A2 Pharmaceutical compositions for treating gastrointestinal distress |
05/22/1991 | EP0428188A2 Novel immunoconjugates and methods for their use in tumor therapy |
05/22/1991 | EP0428107A2 Use of quinolyl-and isoquinolyloxanole-2-ones for the production of a medicament for the treatment of multi-drug resistant tumors |
05/22/1991 | EP0428104A2 Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones |
05/22/1991 | CN1051503A Treatment of conditions and disease |
05/22/1991 | CA2069404A1 Use of optically pure s(-) atenolol for the treatment of cardiovascular disorders |
05/21/1991 | US5017470 Hormones |
05/21/1991 | US5017371 Method for reducing side effects of cancer therapy |
05/16/1991 | WO1991006284A1 Pharmaceutical preparations |
05/16/1991 | DE4035226A1 Use of medicament containing muscarine agonist - to prevent and treat ventricular arrhythmia, especially acute or malignant arrhythmia |
05/15/1991 | EP0427124A2 Antacid tablets |
05/15/1991 | EP0261234B1 Dual phase solvent carrier system |
05/15/1991 | CN1051389A Novel antibodies reactive with human carcinomas |
05/14/1991 | US5015654 Pharmaceutical compositions |
05/14/1991 | US5015481 Stabilized pharmaceutical admixture composition |
05/11/1991 | CA2028733A1 Antacid tablets |
05/08/1991 | EP0426479A1 Use of a composition for the manufacture of a medicament for curing the symptoms of overindulgence |